Ameritas Advisory Services’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-44,232
| Closed | -$64.6K | – | 816 |
|
|
2023
Q2 | $64.6K | Sell |
44,232
-1,070
| -2% | -$1.56K | 0.01% | 539 |
|
|
2023
Q1 | $94.9K | Hold |
45,302
| – | – | ﹤0.01% | 1023 |
|
|
2022
Q4 | $51.2K | Hold |
45,302
| – | – | ﹤0.01% | 863 |
|
|
2022
Q3 | $74K | Hold |
45,302
| – | – | ﹤0.01% | 742 |
|
|
2022
Q2 | $59K | Buy |
45,302
+1,070
| +2% | +$1.39K | ﹤0.01% | 784 |
|
|
2022
Q1 | $71K | Hold |
44,232
| – | – | ﹤0.01% | 818 |
|
|
2021
Q4 | $92K | Buy |
+44,232
| New | +$92K | ﹤0.01% | 798 |
|